| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8317953 | Clinical Biochemistry | 2012 | 5 Pages |
Abstract
⺠Treatment of acute lymphoblastic leukemia (ALL) in adults presents a formidable challenge. ⺠ALL patients suffer from refractory or recurrent disease and cannot be cured with conventional chemotherapy. ⺠We examined the levels of survivin and TNF- in the circulation of adult patients with newly diagnosed untreated ALL and after initial treatment. ⺠Higher levels of survivin and TNF- were detected in ALL patients that were correlated with risk factors in ALL as peripheral blast cells and Philadelphia chromosome.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Manal Basyouni Ahmed, Hanan Hussien Shehata, Mona Moussa, Tamer Mohamed Ibrahim,